NP / PA
Pavese, Heidi
Pavese, Heidi was paid $205K by Medicaid between Jan 2018 and Oct 2024, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoPAVESE, HEIDI
ROCK HILL, NY 12775
ROCK HILL, NY 12775
33aNPI1861681926assigned 10/15/2007
33bProvider typeFamily Nurse Practitioner
28Total paid$205K
24GClaims3,661
24DCodes billed14
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Nurse Practitioner providers in New York
Rank by total paid#51 of 1,582
Median peer was paid$2K
This provider vs. median89×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 150 | $8K | |
| 2019 | 586 | $27K | |
| 2020 | 610 | $34K | |
| 2021 | 912 | $67K | |
| 2022 | 973 | $50K | |
| 2023 | 243 | $13K | |
| 2024incomplete | 187 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 1,609 | 1,533 | $117K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 1,053 | 994 | $69K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.2% | 47 | 45 | $7K |
| 80050 | General health panel | 2.1% | 111 | 111 | $4K |
| 80061 | Lipid panel | 1.3% | 212 | 212 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 198 | 198 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | 25 | $2K |
| 96127 | <1% | 188 | 185 | $904.64 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 24 | 24 | $550.00 |
| 90686 | <1% | 27 | 27 | $354.75 | |
| 86803 | <1% | 13 | 13 | $185.51 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | 13 | $131.25 |
2 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 128 | $48.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.